Weekly vs 3-weekly cisplatin: a retrospective cohort study

被引：0
|
作者：
Saerens, Michael [1 ,2 ]
Van den Broeck, Alexander [2 ]
de Weghe, Geertrui Van [2 ]
Wouter, Huvenne [3 ,4 ]
Peter, Tomassen [3 ,4 ]
Wouter, Bauters [5 ]
Vermassen, Tijl [1 ,2 ]
Sarah, Deschuymer [6 ,7 ]
Rottey, Sylvie [1 ,2 ,8 ]
Duprez, Frederic [6 ,7 ]
机构：
[1] Ghent Univ Hosp, Med Oncol, Ghent, Belgium
[2] Univ Ghent, Basic & Appl Med Sci, Ghent, Belgium
[3] Ghent Univ Hosp, Head & Neck Surg, Ghent, Belgium
[4] Univ Ghent, Head & Skin, Ghent, Belgium
[5] Ghent Univ Hosp, Radiol, Ghent, Belgium
[6] Ghent Univ Hosp, Radiotherapy, Ghent, Belgium
[7] Univ Ghent, Human Struct & Repair, Ghent, Belgium
[8] Ghent Univ Hosp, Drug Res Unit, Ghent, Belgium
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 192卷
关键词：
Chemoradiotherapy; cisplatin; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
229
引用
收藏
页码：S280 / S283
页数：5
相关论文
共 50 条
  • [31] Randomized Controlled Study Comparing Efficacy and Toxicity of Weekly vs. 3-Weekly Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Tousif, Devale
    Sarathy, Vinu
    Kumar, Rajesh
    Naik, Radheshyam
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Weekly versus 2-weekly versus 3-weekly docetaxel to treat metastatic castration-resistant prostate cancer
    Yuk, Hyeong Dong
    Kim, Miso
    Keam, Bhumsuk
    Ku, Ja Hyeon
    Kwak, Cheol
    Jeong, Chang Wook
    PROSTATE INTERNATIONAL, 2024, 12 (04) : 219 - 223
  • [33] A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules
    Boddy, AV
    Plummer, ER
    Todd, R
    Sludden, J
    Griffin, M
    Robson, L
    Cassidy, J
    Bissett, D
    Bernareggi, A
    Verrill, MW
    Calvert, AH
    CLINICAL CANCER RESEARCH, 2005, 11 (21) : 7834 - 7840
  • [34] Weekly versus 3-weekly cisplatin along with radiotherapy for locoregionally advanced non-nasopharyngeal head and neck cancers: Is the equipoise in literature addressed yet?
    Chatterjee, Sataksi
    Kiyota, Naomi
    Vaish, Richa
    Sharma, Atul
    Tahara, Makoto
    Noronha, Vanita
    Prabhash, Kumar
    D'Cruz, Anil
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (06): : 1594 - 1603
  • [35] Weekly versus 3-Weekly Regimens of Carboplatin and Paclitaxel in Metastatic NSCLC: A Real-World Data
    Waissengrin, B.
    Stern, T.
    Shamai, S.
    Merimsky, O.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S494 - S494
  • [36] A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
    Meyer, T.
    Kirkwood, A.
    Roughton, M.
    Beare, S.
    Tsochatzis, E.
    Yu, D.
    Davies, N.
    Williams, E.
    Pereira, S. P.
    Hochhauser, D.
    Mayer, A.
    Gillmore, R.
    O'Beirne, J.
    Patch, D.
    Burroughs, A. K.
    BRITISH JOURNAL OF CANCER, 2013, 108 (06) : 1252 - 1259
  • [37] A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
    T Meyer
    A Kirkwood
    M Roughton
    S Beare
    E Tsochatzis
    D Yu
    N Davies
    E Williams
    S P Pereira
    D Hochhauser
    A Mayer
    R Gillmore
    J O'Beirne
    D Patch
    A K Burroughs
    British Journal of Cancer, 2013, 108 : 1252 - 1259
  • [38] Comparative study on hemato- and nephrotoxicity profile of weekly versus every 3-weekly cisplatin dosage during induction chemotherapy in locally advanced head neck squamous cell carcinoma
    Chakraborty, Adity
    Bhattacharjee, Abhinandan
    Nath, Amlan Jyoti
    Deb, Shibashis
    Rathor, Aakanksha
    EGYPTIAN JOURNAL OF OTOLARYNGOLOGY, 2021, 37 (01):
  • [39] Comparative study on hemato- and nephrotoxicity profile of weekly versus every 3-weekly cisplatin dosage during induction chemotherapy in locally advanced head neck squamous cell carcinoma
    Adity Chakraborty
    Abhinandan Bhattacharjee
    Amlan Jyoti Nath
    Shibashis Deb
    Aakanksha Rathor
    The Egyptian Journal of Otolaryngology, 2021, 37
  • [40] Concurrent chemoradiotherapy with 3-weekly versus weekly cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: A phase 3 multicentre randomised controlled trial (ChiCTR-TRC-12001979).
    Liang, Hu
    Xia, Wei-Xiong
    Lv, Xing
    Sun, Rui
    Zeng, Qi
    Li, Si -Wei
    Mo, Hao-Yuan
    Han, Fei
    Luo, Dong-Hua
    Ye, Yan-Fang
    Yang, Jing
    Ke, Liang-Ru
    Guo, Ling
    Chen, Ming-Yuan
    Cao, Ka-Jia
    Zhao, Chong
    Mai, Hai-Qiang
    Qian, Chao-Nan
    Guo, Xiang
    Yanqun, Xiang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345